Featured
Pharma rejoins Medicines Australia
Several years after leaving the industry body, this company has returned as a Class 1 member, saying the innovative medicines sector is strongest when it works together
Industry & Companies
What's the ROI of government mRNA initiatives?
Millions of dollars have been spent by the Victorian Government to nurture the mRNA industry in the state, and a new Impact Report details whether it's delivered
Jobs & Workplace
Big Pharma picks Sydney CBD for new HQ
General Manager announces a “fresh start” for the pharma in a slick new office space with the latest technology and design to enable flexible-based working plus connection with patients and partners
Regulatory & Reimbursement
The secrecy that hampers PBAC decisions
There can be clear disagreements over the price which should be paid for a drug, but some features of the reimbursement system mean neither side really knows what the other expects
Regulatory & Reimbursement
September PBS listings climb to eight
Six pharmas have expanded their drugs on the PBS this month - including the first biologic added to the scheme for adults with uncontrolled COPD - with two companies scoring a double win
Leadership & People
Who’s up for a 2026 PRIME Award?
The 22nd PRIME Awards have attracted entries from more organisations than ever before making this one of the strongest and most competitive fields in the event's history. See which pharmas have topped the shortlist
Featured
Who has the most effective MSLs, and why?
A survey of US oncologists has revealed what separates highly effective MSL teams from average ones and without prompting, doctors named the companies that stand out
Regulatory & Reimbursement
CSL lowers prices in Trump MFN deal
CSL and eight other pharmas have signed a Most Favoured Nation deal with the US, with the Aussie giant saying it does not anticipate any 'material impact' during fiscal year 2027
Industry & Companies
Pharma deal to ramp up retail reach in Australia
New commercial collaboration bringing together 'complementary strengths' of two pharmas is a stepping-stone to further collaboration across a broad pipeline
Regulatory & Reimbursement
CEO raises red flag on PBS transparency
Boss warns there is currently no mechanism to disclose a drug’s commercial history citing the example of a treatment originally developed by Big Tobacco
Jobs
Industry & Companies
$10M for Aussie infectious diseases innovation
Six Australian companies addressing significant local and global unmet health needs in infectious diseases are getting support to break into commercial success
Regulatory & Reimbursement
Who's at the PBAC's next meeting?
PBAC will consider eight submissions with three companies laying the groundwork to secure a broad PBS listing recommendation for their immunotherapies
Regulatory & Reimbursement
Company scores double PBS win
It's been quite the week for this company which announced a new General Manager on Friday and from tomorrow, two of its biggest drugs will be expanded
Featured
World's biggest drug wins broad PBS listing
After a gruelling decade-long battle, a milestone PBS listing will see this oncology blockbuster made available to thousands of Australians living with certain advanced and metastatic cancers, including rare cancers
Industry & Companies
Patients choosing between meds or meals
The Leukaemia Foundation has launched a campaign to improve financial assistance to people diagnosed with blood cancer, so people don't need to forgo treatment due to lack of funds
Latest
Spring blooms with fresh PBS listing
First-of-its-kind treatment in an area of unmet need scores a Spring PBS listing with the company's GM underlining the importance of innovative medicines for economic growth
Regulatory & Reimbursement
TGA reins in breast cancer label
Australia's regulator has narrowed the patient population eligible for a breast cancer drug, after initially granting approval for a broader population than other major jurisdictions
Leadership & People
Company names new Aussie Country Leader
Almost six months after the departure of its General Manager, this company has recruited the leader of a rival pharma as its next Aussie boss
Leadership & People
ANZ GM lifts the lid on best workplace culture
Sandoz ANZ General Manager, Clint Holland, has pulled back the curtain on what makes the biosimilar & generics giant one of Australia’s Best Workplaces
Industry & Companies
Global boss: Why strong science isn't enough
Visting Australia this week to join a discussion about the need for policy and access to keep pace with innovation and scientific ambition
Industry & Companies
Who's been crowned an Aussie Best Workplace?
Twelve health sector organisations, including three pharmas, have made the exclusive Best Workplaces in Australia 2026 list
Industry & Companies
King Kong of drugs a revenue booster
While debate over public funding of weight loss drugs continues, Sigma has reported "above the norm" sales growth driven by GLP-1s
Regulatory & Reimbursement
Single-pill triple therapy wins TGA tick
The TGA has approved a new single-pill triple therapy for hypertension as Johnson & Johnson and Dr Falk Pharma expand their franchises
- Other News Aussie patients name industry's best
- Regulation & Legal Double recognition for Aussie IP strategist
- Industry & Companies The pharma influencer adding emotion to data
- Industry & Companies Which pharma nets $1.4M... every 20 minutes?
- Jobs & Workplace Long-timers jump to new companies
- Regulatory & Reimbursement Calls for PBS co-payment freeze
- Jobs & Workplace Salary rift emerges across pharma
- Jobs & Workplace Who will survive the next pharma downsize?
- Industry & Companies Aussie jobs to go after trial failure
- Leadership & People How Dolly quietly reshaped pharma
